Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells. (Q39154659)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 May 2013

Language	Label	Description	Also known as
English	Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells.	scientific article published on 9 May 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Kingston H Mills

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Karen C Galvin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Lydia Dyck

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Neil A Marshall

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Anna M Stefanska

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Kevin P Walsh

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Sarah C Higgins

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Lara S Dungan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

9 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

62

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1273-1282

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23657628%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

RALDH3, a retinaldehyde dehydrogenase that generates retinoic acid, is expressed in the ventral retina, otic vesicle and olfactory pit during mouse development.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Chromosomal integration of retinoic acid response elements prevents cooperative transcriptional activation by retinoic acid receptor and retinoid X receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Downregulation of Th17 cells in the small intestine by disruption of gut flora in the absence of retinoic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Regulating the immune response to tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

The roles of antigen-specificity, responsiveness to transforming growth factor-β and antigen-presenting cell subsets in tumour-induced expansion of regulatory T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Dendritic cell-mediated T cell polarization

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: a case series and review

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1432-8

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39154659&oldid=2202622560"